Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Mar;40(3):381-388.
doi: 10.14670/HH-18-785. Epub 2024 Jun 25.

Clinicopathological and molecular features of genome-stable colorectal cancers

Affiliations

Clinicopathological and molecular features of genome-stable colorectal cancers

Lingyan Jin et al. Histol Histopathol. 2025 Mar.

Abstract

Colorectal cancers (CRCs) are traditionally divided into those with either chromosomal instability (CIN) or microsatellite instability (MSI). By utilizing TCGA data, the Laird team found a subset of CRCs, namely, genome-stable CRCs (GS CRCs), which lack both CIN and MSI. Although the molecular features of GS CRCs have been described in detail, the clinicopathological features are not well defined. A total of 437 CRCs were analyzed for copy number variation (CNV) statuses in eight genes (ARID1A, EGFR, FGFR1, KDM5B, MYBL2, MYC, SALL4, and SETDB1) using droplet-digital PCR. CRCs that showed CNV in ≤ one gene and no MSI were defined as GS-like CRCs. Clinicopathological and molecular features of GS-like CRCs were compared with those of CIN-like CRCs. GS-like CRCs comprised 4.6% of CRCs and showed a predilection toward the proximal colon, lower nuclear optical density, KRAS mutation, PIK3CA mutation, and aberrant expression of KRT7. Survival analysis showed no significant difference between the three subgroups. Through our study, the GS-like subtype was found to comprise a minor proportion of CRCs and have proclivity toward a proximal bowel location, hypochromatic tumor nuclei, aberrant KRT7 expression, and a high frequency of KRAS and PIK3CA mutations.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Al-Sohaily S., Biankin A., Leong R., Kohonen-Corish M. and Warusavitarne J. (2012). Molecular pathways in colorectal cancer. J. Gastroenterol. Hepatol. 27, 1423-1431. - PubMed
    1. Bae J.M., Lee T.H., Cho N.Y., Kim T.Y. and Kang G.H. (2015). Loss of CDX2 expression is associated with poor prognosis in colorectal cancer patients. World J. Gastroenterol. 21, 1457-1467. - PMC - PubMed
    1. Bae J.M., Kim J.H. and Kang G.H. (2016). Molecular subtypes of colorectal cancer and their clinicopathologic features, with an emphasis on the serrated neoplasia pathway. Arch. Pathol. Lab. Med. 140, 406-412. - PubMed
    1. Bae J.M., Kim J.H., Kwak Y., Lee D.W., Cha Y., Wen X., Lee T.H., Cho N.Y., Jeong S.Y., Park K.J., Han S.W., Lee H.S., Kim T.Y. and Kang G.H. (2017). Distinct clinical outcomes of two CIMP-positive colorectal cancer subtypes based on a revised CIMP classification system. Br. J. Cancer 116, 1012-1020. - PMC - PubMed
    1. Bakker B., Taudt A., Belderbos M.E., Porubsky D., Spierings D.C., de Jong T.V., Halsema N., Kazemier H.G., Hoekstra-Wakker K., Bradley A., de Bont E.S., van den Berg A., Guryev V., Lansdorp P.M., Colome-Tatche M. and Foijer F. (2016). Single-cell sequencing reveals karyotype heterogeneity in murine and human malignancies. Genome Biol. 17, 115. - PMC - PubMed

Substances